Circulation: Heart Failure considers for publication content related to heart failure, mechanical circulatory support and heart transplant science and medicine, including studies conducted in humans or analyses of human data, as well as preclinical studies that have direct clinical correlation or relevance. As a primarily clinical journal, few basic and preclinical studies are ultimately published. Those that will be considered are novel, and significantly and directly advance the field of heart failure. The editors are especially interested in basic science studies directly related to heart failure that are highly informative and translatable to human disease and are conducted in vertebrate models. Less than 15% of submitted articles are ultimately published. Work not directly involving heart failure or heart failure therapies will not be considered, including work on mechanisms of myocardial infarction, reperfusion injury, or arrhythmia in the absence of heart failure substrate.

《循环：心力衰竭》杂志考虑发表与心力衰竭、机械循环支持和心脏移植科学和医学相关的内容，包括对人类进行的研究或对人类数据的分析，以及具有直接临床相关性或相关性的临床前研究。作为一本主要针对临床的杂志，最终发表的基础研究和临床前研究很少。那些将被考虑的研究都是新颖的，并且对心力衰竭领域有重大而直接的推动作用。编辑们对与心力衰竭直接相关的基础科学研究特别感兴趣，这些研究信息量大，可转化为人类疾病，并在脊椎动物模型中进行。提交的文章中，只有不到 15% 最终得以发表。不直接涉及心力衰竭或心力衰竭治疗的研究将不予考虑，包括在没有心力衰竭底物的情况下研究心肌梗死、再灌注损伤或心律失常的机制。

该刊已被国际权威数据库SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-心血管系统领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为7.8，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。